Your browser doesn't support javascript.
loading
Reporting of randomized factorial trials was frequently inadequate.
Kahan, Brennan C; Tsui, Michael; Jairath, Vipul; Scott, Anna Mae; Altman, Douglas G; Beller, Elaine; Elbourne, Diana.
Afiliação
  • Kahan BC; Pragmatic Clinical Trials Unit, Queen Mary University of London, London, UK. Electronic address: b.kahan@qmul.ac.uk.
  • Tsui M; Schulich School of Medicine and Dentistry, London, Ontario, Canada.
  • Jairath V; Department of Medicine, University of Western Ontario, London, Ontario, Canada; Department of Epidemiology and Biostatistics, University of Western Ontario, London, Ontario, Canada.
  • Scott AM; Centre for Research in Evidence-Based Practice (CREBP), Bond University, Robina, Queensland, Australia.
  • Altman DG; Centre for Statistics in Medicine, University of Oxford, Oxford, UK.
  • Beller E; Centre for Research in Evidence-Based Practice (CREBP), Bond University, Robina, Queensland, Australia.
  • Elbourne D; Medical Statistics Department, London School of Hygiene & Tropical Medicine, London, UK.
J Clin Epidemiol ; 117: 52-59, 2020 01.
Article em En | MEDLINE | ID: mdl-31585174
OBJECTIVES: Factorial designs can allow efficient evaluation of multiple treatments within a single trial. We evaluated the design, analysis, and reporting in a sample of factorial trials. STUDY DESIGN AND SETTING: Review of 2 × 2 factorial trials evaluating health-related interventions and outcomes in humans. Using Medline, we identified articles published between January 2015 and March 2018. We randomly selected 100 articles for inclusion. RESULTS: Most trials (78%) did not provide a rationale for using a factorial design. Only 63 trials (63%) assessed the interaction for the primary outcome, and 39/63 (62%) made a further assessment for at least one secondary outcome. 12/63 trials (19%) identified a significant interaction for the primary outcome and 16/39 trials (41%) for at least one secondary outcome. Inappropriate methods of analysis to protect against potential negative effects from interactions were common, with 18 trials (18%) choosing the analysis method based on a preliminary test for interaction, and 13% (n = 10/75) of those conducting a factorial analysis including an interaction term in the model. CONCLUSION: Reporting of factorial trials was often suboptimal, and assessment of interactions was poor. Investigators often used inappropriate methods of analysis to try to protect against adverse effects of interactions.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Projetos de Pesquisa / Ensaios Clínicos como Assunto Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Projetos de Pesquisa / Ensaios Clínicos como Assunto Idioma: En Ano de publicação: 2020 Tipo de documento: Article